GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » 3-Year EPS without NRI Growth Rate

CME (CME Group) 3-Year EPS without NRI Growth Rate : 15.40% (As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is CME Group 3-Year EPS without NRI Growth Rate?

CME Group's EPS without NRI for the three months ended in Mar. 2025 was $2.80.

During the past 12 months, CME Group's average EPS without NRI Growth Rate was 12.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 15.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 9.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of CME Group was 45.70% per year. The lowest was -14.90% per year. And the median was 13.70% per year.


Competitive Comparison of CME Group's 3-Year EPS without NRI Growth Rate

For the Financial Data & Stock Exchanges subindustry, CME Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CME Group's 3-Year EPS without NRI Growth Rate Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CME Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where CME Group's 3-Year EPS without NRI Growth Rate falls into.


;
;

CME Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


CME Group  (NAS:CME) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


CME Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of CME Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


CME Group Business Description

Industry
Address
20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Executives
Daniel G Kaye director 1742 APPLEBY ROAD, INVERNESS IL 60067
Jonathan L Marcus officer: Sr MD General Counsel 20 SOUTH WACKER DRIVE, CHICAGO IL 60606
Phyllis M Lockett director 20 S. WACKER DR., CHICAGO IL 60606
Charles P Carey director 20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman director 20 S. WACKER DR, CHICAGO IL 60606
Derek Sammann officer: Managing Dir Financial Product 20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Larry G Gerdes director ONE GLENLAKE PARKWAY, SUITE 1325, ATLANTA GA 30326
William R Shepard director 20 S. WACKER DR, CHICAGO IL 60606
Howard J Siegel director 20 S. WACKER DR, CHICAGO IL 60606
Terrence A Duffy director 20 S. WACKER DR, CHICAGO IL 60606
Suzanne Sprague officer: Sr MD Global Head of Clearing 20 SOUTH WACKER DRIVE, 18S, CHICAGO IL 60606
Hilda Harris Piell officer: MD, Organizational Development 20 S. WACKER DRIVE, CHICAGO IL 60606
Julie Winkler officer: Chief Commercial Officer 20 S. WACKER DR., CHICAGO IL 60606
Ken Vroman officer: MD & Chief Corp Dev Officer 20 S. WACKER DR., CHICAGO IL 60606